Kidney transplantation.
Fifty patients per million per annum in Australia suffer from end stage renal failure and could be helped by dialysis and transplantation. At the present time, only half this number are being referred to renal units in Australia where we believe facilities are available to help all that could benefit from this treatment. This article discusses patient selection, the results and hazards of renal transplantation. As a result of this treatment programme, 50 per cent of patients can expect virtually a normal life with a kidney graft functioning five years or more.
D001379:Azathioprine / Q000627:therapeutic use; D006084:Graft Rejection / Q000187:drug effects; D006650:Histocompatibility Testing; D006801:Humans; D007676:Kidney Failure, Chronic / Q000628:therapy; D016030:Kidney Transplantation; D011239:Prednisolone / Q000627:therapeutic use; D006435:Renal Dialysis; D014019:Tissue Donors; D014181:Transplantation Immunology / Q000187:drug effects
D011239:Prednisolone; D001379:Azathioprine